Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-28T12:36:10.264Z Has data issue: false hasContentIssue false

Studies of experimental rhinovirus type 2 infections in polar isolation and in England

Published online by Cambridge University Press:  15 May 2009

M. J. Holmes
Affiliation:
British Antarctic Survey
Sylvia E. Reed
Affiliation:
Medical Research Council Common Cold Unit, Harvard Hospital, Salisbury, SP2 8BW, Wilts.
E. J. Stott
Affiliation:
Institute for Research on Animal Diseases, Compton, RG16 0NN, Berks.
D. A. J. Tyrrell
Affiliation:
Clinical Research Centre, Harrow, HA1 3UJ, Middlesex
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

After five months of total isolation a wintering party of seventeen British Antarctic Survey (BAS) personnel was inoculated under double blind conditions with placebo, or rhinovirus type 2 which had been propagated in tissue culture. The clinical and virological responses of these subjects were compared with those of volunteers in England who received a similar dose of the same strain. The virus used was apparently partly attenuated for man; at the dosage used its effects in England were similar to a smaller dose of an unattenuated strain, but in the Antarctic it caused relatively severe infections. Both the symptoms and the laboratory evidence of virus infection appeared to be more pronounced in the BAS subjects than in the volunteers in England who received the same challenge. In the former group the infection readily spread to those who were originally given placebo. In the BAS subjects serum antibody titres were well maintained during the isolation period but a significant fall in nasal immunoglobulin concentration was recorded during the 5 months of isolation after the virus challenge. Possible mechanisms for the increased sensitivity to rhinovirus of subjects who have been totally isolated in a small closed community are discussed.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1976

References

REFERENCES

Abs, O. (1930). Über Epidemien von unspecifischen Katarrhen der Luftwege auf Svalban (Spitzbergen). Skrifter om Svalband oq Ishavet No. 32.Google Scholar
Bradburne, A. F., Bynoe, M. L. & Tyrrell, D. A. J. (1967). Effects of a “new” human respiratory virus in volunteers. British Medical Journal iii, 767.CrossRefGoogle Scholar
Buscho, R. F., Perkins, J. C., Knopf, H. L. S., Kapikian, A. Z. & Chanock, R. M. (1972). Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine. Journal of Immunology 108, 169.CrossRefGoogle ScholarPubMed
Butler, W. T., Waldmann, T. A., Rossen, R. D., Douglas, R. G. & Couch, R. B. (1970). Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. Journal of Immunology 105, 584.CrossRefGoogle Scholar
Cameron, A. S. & Moore, B. W. (1968). The epidemiology of respiratory infection in an isolated Antarctic community. Journal of Hygiene 66, 427.CrossRefGoogle Scholar
Cate, T. R., Douglas, R. G. & Couch, R. B. (1969). Interferon and resistance to upper respiratory virus illness. Proceedings of the Society for Experimental Biology and Medicine 131, 631.CrossRefGoogle ScholarPubMed
Chaniot, S. C. M., Holmes, M. J., Stott, E. J. & Tyrrell, D. A. J. (1974). An investigation of media for long term storage of three respiratory viruses. Archiv für die gesamte Virus-forschung 44, 396.CrossRefGoogle ScholarPubMed
Couch, R. B., Douglas, R. G., Lindgren, K. M., Gerone, P. J. & Knight, V. (1970). Airborne transmission of respiratory infection with Coxsackievirus A type 21. American Journal of Epidemiology 91, 78.CrossRefGoogle ScholarPubMed
D'alessio, D., Dick, C. R. & Dick, E. C. (1972). Transmission studies in volunteers infected with rhinovirus type 55. International Virology 2 (ed. Melnick, J. L.), p. 115. Basel: S. Karger.Google Scholar
Douglas, R. G. & Couch, R. B. (1969). Attenuation of rhinovirus type 15 for humans. Nature, London 223, 213.CrossRefGoogle ScholarPubMed
Douglas, R. G. Jr, Lindgren, K. M. & Couch, R. B. (1968). Exposure to cold environment and rhinovirus common cold. Failure to demonstrate effects. New England Journal of Medicine 279, 742.CrossRefGoogle Scholar
Eadie, M. B., Stott, E. J. & Grist, N. R. (1966). Virological studies in chronic bronchitis. British Medical Journal ii, 671.CrossRefGoogle Scholar
Holmes, M. J. (1973). Respiratory virus disease in the Antarctic: Immunological studies. In Polar Human Biology(ed. Edholm, O. G. & Gunderson, E. K. E.), p. 125. London: Heinemann Medical Books.CrossRefGoogle Scholar
Holmes, M. J. & Allen, T. (1973). Viral respiratory disease in isolated communities: a review. British Antarctic Survey Bulletin 35, 23.Google Scholar
Holmes, M. J., Allen, T. R., Bradburne, A. F. & Stott, E. J. (1971). Studies of respiratory viruses in personnel at an Antarctic base. Journal of Hygiene 69, 187.CrossRefGoogle ScholarPubMed
Leading Article, (1973). Ascorbic acid and common colds. British Medical Journal iii, 131.Google Scholar
Lundkvist, U. & Ceska, M. (1972). Effect of non-ionic polymers on the formation of immuno-precipitates in single radial immunodiffusion technique. Immunology 23, 413.Google Scholar
Paul, J. H. & Freese, H. L. (1933). An epidemiological and bacteriological study of the ‘common cold’ in an isolated Arctic community (Spitzbergen). American Journal of Hygiene 17, 517.Google Scholar
Perkins, J. C., Tucker, D. N., Knopf, H. L. S., Wenzel, R. P., Kapikian, A. Z. & Chanock, R. M. (1969). Comparison of the protective effect of neutralizing antibody in serum and nasal secretion in experimental rhinovirus 13 illness. American Journal of Epidemiology 90, 519.CrossRefGoogle ScholarPubMed
Stenhouse, A. C. (1967). Rhinovirus infection in acute exacerbations of chronic bronchitis: a controlled prospective study. British Medical Journal iii, 461.CrossRefGoogle Scholar
Stott, E. J., Eadie, M. B. & Grist, N. R. (1969). Rhinovirus infections of children in hospital, isolation of 3 possible new rhinovirus serotypes. American Journal of Epidemiology 90, 45.CrossRefGoogle Scholar
Stott, E. J. & Tyrrell, D. A. J. (1968). Some improved techniques for the study of rhino-viruses using HeLa cells. Archiv für die gesamte Virusforschung 23, 236.CrossRefGoogle Scholar
Strizova, V., Brown, P. K., Head, B. & Reed, S. E. (1974). The advantages of HeLa cells for isolation of rhinoviruses. Journal of Medical Microbiology 7, 433.CrossRefGoogle ScholarPubMed
Tyrrell, D. A. J. (1963). The use of volunteers. American Review of Respiratory Diseases. 88, 128.Google ScholarPubMed
Tyrrell, D. A. J. (1965). Common Colds and related diseases. London: Edward Arnold.Google Scholar
Tyrrell, D. A. J. (1975). Circulating antibodies and respiratory virus infections. International Symposium on Immunity to Infections of the Respiratory System in Man and Animals, London 1974. Developments in Biological Standardization 28, 152. Basel: Karger.Google Scholar
Tyrrell, D. A. J. & Reed, S. E. (1973). Some possible practical implications of interferon and interference. In Non-specific Factors Influencing Host Resistance(ed. Braun, W. & Ungar, J.), p. 438, Basel: Karger.Google Scholar
Urquhart, G. E. & Stott, E. J. (1970). Rhinoviraemia. British Medical Journal iv, 28.CrossRefGoogle Scholar
Woolley, E. J. S. (1963). Discussion. Symposium on medical problems presented by the Tristan da Cunha community. Transactions of the Royal Society of Tropical Medicine and Hygiene 57, 24.Google Scholar